Overview

Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The investigators will look at TPI-1020 safety and tolerability in mild to moderate asthmatic smoker subjects.
Phase:
Phase 2
Details
Lead Sponsor:
Pharmaxis
Treatments:
Budesonide